BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26076990)

  • 1. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function.
    Kwong RY; Heydari B; Abbasi S; Steel K; Al-Mallah M; Wu H; Falk RH
    Am J Cardiol; 2015 Aug; 116(4):622-9. PubMed ID: 26076990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.
    Habibi M; Lima JA; Khurram IM; Zimmerman SL; Zipunnikov V; Fukumoto K; Spragg D; Ashikaga H; Rickard J; Marine JE; Calkins H; Nazarian S
    Circ Cardiovasc Imaging; 2015 Feb; 8(2):e002769. PubMed ID: 25652181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
    Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis.
    Aquaro GD; Pugliese NR; Perfetto F; Cappelli F; Barison A; Masci PG; Passino C; Emdin M
    Int J Cardiovasc Imaging; 2014 Aug; 30(6):1105-15. PubMed ID: 24789582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
    Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
    Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular magnetic resonance in cardiac amyloidosis.
    Maceira AM; Joshi J; Prasad SK; Moon JC; Perugini E; Harding I; Sheppard MN; Poole-Wilson PA; Hawkins PN; Pennell DJ
    Circulation; 2005 Jan; 111(2):186-93. PubMed ID: 15630027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
    Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
    J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Left Atrial Local Conduction Velocity With Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.
    Fukumoto K; Habibi M; Ipek EG; Zahid S; Khurram IM; Zimmerman SL; Zipunnikov V; Spragg D; Ashikaga H; Trayanova N; Tomaselli GF; Rickard J; Marine JE; Berger RD; Calkins H; Nazarian S
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002897. PubMed ID: 26917814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
    McLellan AJ; McKenzie SC; Taylor AJ
    Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
    Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
    Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.
    Lyne JC; Petryka J; Pennell DJ
    Eur Heart J; 2008 Jan; 29(2):212. PubMed ID: 17704093
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.
    Zhao L; Tian Z; Fang Q
    BMC Cardiovasc Disord; 2016 Jun; 16():129. PubMed ID: 27267362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects.
    Krombach GA; Hahn C; Tomars M; Buecker A; Grawe A; Günther RW; Kühl HP
    J Magn Reson Imaging; 2007 Jun; 25(6):1283-7. PubMed ID: 17520735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Fontana M; Pica S; Reant P; Abdel-Gadir A; Treibel TA; Banypersad SM; Maestrini V; Barcella W; Rosmini S; Bulluck H; Sayed RH; Patel K; Mamhood S; Bucciarelli-Ducci C; Whelan CJ; Herrey AS; Lachmann HJ; Wechalekar AD; Manisty CH; Schelbert EB; Kellman P; Gillmore JD; Hawkins PN; Moon JC
    Circulation; 2015 Oct; 132(16):1570-9. PubMed ID: 26362631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Cardiac MR Imaging in Cardiomyopathies.
    Kramer CM
    J Nucl Med; 2015 Jun; 56 Suppl 4(0 4):39S-45S. PubMed ID: 26033902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.
    Akkaya M; Higuchi K; Koopmann M; Burgon N; Erdogan E; Damal K; Kholmovski E; McGann C; Marrouche NF
    Europace; 2013 Dec; 15(12):1725-32. PubMed ID: 23711578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.